Member Info for Baffyman

Sorry ignore last post, was meant for TRG. Good news, I've topped up in CIZ also.

Put some in my isa today, with med term view on company.
If MM likes it, so do I (ref MM recent report)

Some good recent interviews out and management seem confident. Two good products in late clinical stages, great review in science mag, so had a speculative punt med to long term.

If Fudding was an olympic sport, you'd win the gold medal Wyn.
No sane person would invest in a company and be so negative, unless they wanted to lose money.
Don't see your point here unless no friends and lonely, in which case Samaritans would listen to you.
Binned

Great, this is good comms, releasing info today, rather than getting it lost in yesterdays RNS.
The States are in the ballgame.

Typical FUDDERS on here.
A day with good news and they constantly argue about an off topic subject.
Twats of the highest degree.
Todays RNS was a good piece of news.

Bein, "It’s just getting boring now. The enthusiasm is being ripped apart. "
Suggest either sell up or get a hobby and stop posting on here every few minutes, you're getting toxic.
green bin time

How I read it, it's more of a plan than hope, but that's my interpretation.
"Avacta's Diagnostics Division develops and supplies a broad range of in-vitro diagnostic (IVD) solutions."
"Avacta acquired Launch Diagnostics which serves the hospital pathology laboratory market in the UK and Europe"
" uses its proprietary Affimer® platform to differentiate immunodiagnostic products to provide marketing leading" performance"

??, read the bottom of last RNS:
"Avacta's Diagnostics Division develops and supplies a broad range of in-vitro diagnostic (IVD) solutions. The Division is growing rapidly through an M&A strategy to deliver a global scale IVD business providing market leading solutions for healthcare professionals and consumers to inform treatment and monitor health and well-being. In October 2022, Avacta acquired Launch Diagnostics which serves the hospital pathology laboratory market in the UK and Europe. Avacta Diagnostic's research and development centre in Wetherby, UK uses its proprietary Affimer® platform to differentiate immunodiagnostic products to provide marketing leading performance."

"I love your sense of humour Timster :-)))))) "
Same jokes or childish remarks everyday. Got boring long time ago and binned.

RAH, in my opinion you are actually UNDER estimating the future market.
Potentially AVA6000 could be used on younger and especially older patients due to lack of toxicity.
Bearing in mind there are a lot of older types with cancer, AVA6000 could be used heavily in this area, thus distorting the figures greatly.

Nat West!

Near £60m raise fairly recently!
Try harder fudder

NM
https://twitter.com/MylesMcNulty/status/1634227016256876544

RAH keep the facts coming, just ignore both RD & PL75, they are husband and wife tag team. Green binned them a long time ago.

Elsecar.? Grimy? Dodworth?

haha and you've just declared yours!!!

DTW, good post, it's yes yes yes & yes from me, lol

PS Good timing of incoming money, thought I'd missed out.
Just topped up, would be rude not to.

Obvious why rainbow teeth now on as tugmaster.
He's a right ham shanker.